Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade

Genes Chromosomes and Cancer

Volumn 21, Issue 3, 1998, Pages 195-206

  Mohapatra, Gayatry ^a,b,d   Bollen, Andrew W ^b   Kim, Dong H ^b   Lamborn, Kathleen ^b   Moore, Dan H ^c   Prados, Michael D ^b   Feuerstein, Burt G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER GRADING; CHROMOSOME 10Q; CHROMOSOME ABERRATION; CLONAL ANERGY; CYTOGENETICS; DNA SEQUENCE; GENE AMPLIFICATION; GENE TARGETING; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; METAPHASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID HYBRIDIZATION;

EID: 0031929455     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199803)21:3<195::AID-GCC3>3.0.CO;2-V     Document Type: Article

References (78)

1. Barletta C, Pelicci PG, Kenyon LC, Smith SD, Dalla-Favera R (1987) Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science 235:1064-1067.
2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73:122-129.
3. Bello JM, Leone PE, Nebreda P, Kusak ME, de Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA (1995) Molecular abnormalities of chromosome 19 in malignant gliomas: Preferential involvement of the 19q13.2-q13.4 region. Intl J Oncol 6:655-658.
4. Bigner S, Mark J, Bigner DD (1990) Cytogenetics of human brain tumors, Cancer Genet Cytogenet 47:141-154.
5. Burger PC, Scheithauer BW (1994) Atlas of Tumor Pathology, Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology.
6. Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56:1106-1111.
7. Chung RY, Seizinger BR (1992) Molecular genetics of neurological tumors. J Med Genet 29:361-367.
8. Chung K, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-Whyte ET, Martuza R, Jenkins R, Yandell D, Seizinger BR (1991) TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer 3:323-331.
9. Collins VP (1993) Amplified genes in human gliomas. Semin Cancer Biol 4:27-32.
10. Desmeules M, Mikkelson T, Mao Y (1992) Increasing incidence of primary malignant brain tumors: Influence of diagnostic methods. J Natl Cancer Inst 84:442-445.
11. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI (1995) Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 55:984-988.
12. Ekstrand AJ, Sugawa N, James CD, Collins VP (1992) Amplification and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89:4309-4313.
13. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD (1994) Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9:2313-2320.
14. Ekstrand AJ, Liu L, He J, Hamid ML, Longo N, Collins VP, James CD (1995) Altered subcellular location of an activated and tumor-associated epidermal growth factor receptor. Oncogene 10:1455-1460.
15. Fischer U, Muller HW, Sattler HF, Feiden K, Zang KD, Messe E (1995) Amplification of the MET gene in glioma. Genes Chromosomes Cancer 12:63-65.
16. Foulkes W, Ragoussis J, Stamp G, Allan G, Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67:551-559.
17. Frankel RH, Bayona W, Koslow M, Newcomb EW (1992) P53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433.
18. Fults D, Pedone C (1993) Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer 7:173-177.
19. Greig NH, Ries LG, Yancik R, Rapoport SI (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82:1621-1624.
20. Hamel W, Westphal M, Shepard HM (1993) Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neuro-Oncol 16:159-165.
21. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day R Sr, James CD (1994) CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54:5804-5807.
22. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastorna gene is involved in malignant progression of astrocytomas. Ann Neurol 36:724-721.
23. Hoshino T, Prados M, Wilson CB, Cho KG, Lee KS, Davis RL (1989) Prognostic implications of the bromodeoxyuridine labeling index of high grade gliomas in adults: An overview. Anticancer Res 11:719-728.
24. Ichimura K, Schmidt EE, Yamaguchi N, James CD, Collins VP (1994) A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus. Cancer Res 54:127-130.
25. James CD, Collins VP (1992) Molecular genetic characterization of CNS tumor oncogenesis. Adv Cancer Res 58:121-142.
26. James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86:2858-2862.
27. James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP (1991) Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res 51:1684-1688.
28. James CD, He J, Collins VP, Allalunis-Turner MJ, Day RAD (1993) Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 53:3674-3676.
29. Jay V, Rutka J, Becker LE, Squire J (1994) Pediatric malignant glioma with tubuloreticular inclusions and MYCN amplification. Report of a case with immunohistochemical, ultrastructural, flow cytometric, karyotypíc, and Southern blot analysis. Cancer 73:1987-1993.
30. Jenkins R, Kimmel D, Moertel C, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989) A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
31. Jenkins RB, Alderete B, Mohapatra G, Feuerstein BG (1996) Microsatellite analysis and comparative genomic hybridization detection of glioma chromosome 19 anomalies. Annual Meeting of the Society for Neuro-Oncology, Santa Fe, NM, November 8-10.
32. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization of molecular cytogenetic analysis of solid tumors. Science (Washington, DC) 258:818-821.
33. Kallioniemi A, Kallionicmi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994a) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
34. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994b) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
35. Kamb A, Liu Q, Harshman K, Tavtigian S, Cordon-Cordo C, Skolnick M (1994) Rates of p16(MTS1) mutations in primary tumors with 9p loss. Science (Washington, DC) 264:416-417.
36. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larsson C (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92:169-174.
37. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG (1995) Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Intl J Cancer 60:812-819.
38. Kimmel DW, O'Fallon JR, Scheithauer BW, Kelly PJ, Dewald GW, Jenkins RB (1992) Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol 31:534-542.
39. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236:70-73.
40. Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T (1992) Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma. Tohoku J Exp Med 168:265-269.
41. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
42. Louis DN, Gusella JF (1995) A tiger behind many doors: Multiple genetic pathways to malignant glioma. Trends Genet 11:412-115.
43. Louis DN, von Deimling A, Cluing RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52:31-38.
44. Mellentin JD, Murre C, Donlon TA, McCaw PS, Smith SD, Carroll AJ, McDonald ME, Baltimore D, Cleary ML (1989) The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 246:379-382.
45. Millikin D, Messe E, Vogelstein B, Witkowski C, Trent J (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51:5449-5453.
46. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM (1996) Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56:27-30.
47. Mohapatra G, Kim DH, Feuerstein BG (1995) Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 13:86-93.
48. Muleris M, Almeida A, Dutrillaux AM, Pruchon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux B (1994) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9:2717-2722.
49. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
50. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, Gray JW, Pinkel D (1995) Computer image analysis of comparative genomic hybridization. Cytometry 19:10-26.
51. Ransom DT, Ritland SR, Jenkins RB, Scheithauer B, Kelly PJ, Kimmel DW (1991) Loss of heterozygosity studies in human gliomas. Proc Am Assoc Cancer Res 32:302.
52. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH (1995) Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10:2243-2246.
53. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739.
54. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP (1994a) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299-4303.
55. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994b) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175-1190.
56. Rey JA, Bello MJ, Jimenez-Lara AM, Vaquero J, Kusak ME, de Campos JM, Sarasa JL, Pestana A (1992) Loss of heterozygosity for distal markers on 22q in human gliomas. Intl J Cancer 51:703-706.
57. Rey JA, Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Pestana A (1993) Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet 66:1-10.
58. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. 1st Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
59. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M (1996) Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J Neuropathol Exp Neurol 55:81-87.
60. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Reid T, Witkowski R, Cremer T (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144:1203-1218.
61. Silverberg E, Boring CC, Squires TS (1990) Cancer statistics. CA Cancer J Clin 40:9-26.
62. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:156-162.
63. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Strokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo WL (1994) Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Res 5416:4257-4260.
64. Thiel G, Losanowa T, Kintzel D, Nisch G, Martin H, Vorpahl K, Witlowski R (1992) Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58:109-120.
65. Trent J, Meltzer P, Roscnblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470-473.
66. Venter DJ, Thomas DG (1991) Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 63:753-757.
67. Venter DJ, Bevan KL, Ludwig RL, Riley TE, Jat PS, Thomas DG, Noble MD (1991) Retinoblastoma gene deletion in human glioblastomas. Oncogene 6:445-448.
68. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR (1992a) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52:2987-2990.
69. von Deimling A, Louis DN, von Ammon K, Peterson I, Wiestler OD, Seizinger BR (1992b) Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligoden-drogliomas, and mixed gliomas. Cancer Res 52:4277-4279.
70. von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN, Wiestler OD (1994) Deletion mapping of chromosome 19 in human gliomas. Int J Cancer 57:676-680.
71. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55:20-23.
72. Watanabe K, Nagai M, Wakai S, Arai T, Kawashima K (1990) Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol 80:251-254.
73. Weber R, Sable M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T (1996a) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983-994.
74. Weber R, Sommer C, Albert F, Kiessling M, Cremer T (1996b) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest 74:108-119.
75. Wilkie TM, Gilbert DJ, Olsen AS, Chen XN, Amatruda TT, Korenberg JR, Trask BJ, de Jong P, Reed RR, Simon MI, et al. (1992) Evolution of the mammalian G protein alpha subunit multigene family. Nat Genet 1:85-91.
76. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill Dea (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington, DC) 265:2088-2090.
77. Wu JK, Darras BT (1992) Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas. Neurol Res 14:39-44.
78. Wullich B, Sattler HP, Fischer U, Messe E (1994) Two independent amplification events on chromosome 7 in glioma: Amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14:577-579.